Search
for
Sort by
Research 661–690 of 877
- Treatment of pediatric alopecia areata: A systematic review
- Poliosis circumscripta: Overview and underlying causes
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Female pattern alopecia: current perspectives
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Alopecia: A review of laser and light therapies
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Eyebrow Loss
- Genetic Hair Disorders: A Review
- Alopecia and Associated Toxic Agents: A Systematic Review
- Treating Alopecia Areata: Current Practices Versus New Directions
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Treatments for alopecia areata: A systematic review and network meta‐analysis
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Delivery systems in nanocosmeceuticals
- JAK inhibition decreases the autoimmune burden in Down syndrome
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Adaptive Triboelectric Nanogenerators for Long-Term Self-Treatment: A Review
- Scalp cooling to prevent chemotherapy-induced alopecia
- A review of environmental and health effects of synthetic cosmetics
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus